Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 2
2000 2
2001 4
2002 5
2003 3
2004 4
2005 2
2006 1
2007 3
2008 4
2009 1
2010 4
2011 6
2012 6
2013 7
2014 8
2015 7
2016 11
2017 8
2018 6
2019 4
2020 9
2021 4
2022 9
2023 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Metabolomic profiles predict individual multidisease outcomes.
Buergel T, Steinfeldt J, Ruyoga G, Pietzner M, Bizzarri D, Vojinovic D, Upmeier Zu Belzen J, Loock L, Kittner P, Christmann L, Hollmann N, Strangalies H, Braunger JM, Wild B, Chiesa ST, Spranger J, Klostermann F, van den Akker EB, Trompet S, Mooijaart SP, Sattar N, Jukema JW, Lavrijssen B, Kavousi M, Ghanbari M, Ikram MA, Slagboom E, Kivimaki M, Langenberg C, Deanfield J, Eils R, Landmesser U. Buergel T, et al. Among authors: klostermann f. Nat Med. 2022 Nov;28(11):2309-2320. doi: 10.1038/s41591-022-01980-3. Epub 2022 Sep 22. Nat Med. 2022. PMID: 36138150 Free PMC article.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group. van Schaik IN, et al. Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Lancet Neurol. 2018. PMID: 29122523 Free article. Clinical Trial.
[Hallucinations in Patients with Idiopathic Parkinson's Disease].
Weiss D, Höglinger G, Klostermann F, Weise D, Zeuner KE, Reichmann H. Weiss D, et al. Among authors: klostermann f. Fortschr Neurol Psychiatr. 2022 Oct;90(10):456-464. doi: 10.1055/a-1670-7111. Epub 2021 Nov 29. Fortschr Neurol Psychiatr. 2022. PMID: 34844278 Review. German.
Lemierre syndrome: case report.
Veras RO, Barasuol LL, de Lira CP, Klostermann FC, Müller LS, Nercolini LE, Nogueira GF. Veras RO, et al. Among authors: klostermann fc. J Vasc Bras. 2018 Oct-Dec;17(4):337-340. doi: 10.1590/1677-5449.002418. J Vasc Bras. 2018. PMID: 30787954 Free PMC article.
Altered event processing in persons with Parkinson's disease.
Wyrobnik M, van der Meer E, Klostermann F. Wyrobnik M, et al. Among authors: klostermann f. Psychophysiology. 2022 Jul;59(7):e14021. doi: 10.1111/psyp.14021. Epub 2022 Feb 9. Psychophysiology. 2022. PMID: 35141901
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups. Rascol O, et al. Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8. Parkinsonism Relat Disord. 2022. PMID: 35227940 Free article. Clinical Trial.
110 results